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ABSTRACT
Purpose: The influence of treatment access regulation and technological resources on the mortality profile of acute biliary
pancreatitis (ABP) was evaluated. Methods: The cases seen in a tertiary hospital were studied during two periods of time:
1995-1999 and 2000-2004, i.e., before and after the implementation of medical regulation. Results: Among the 727 patients
with acute pancreatitis, 267 had ABP and were classified according to APACHE II scores. The cases being referred to the
tertiary hospital decreased from 441 to 286 (p < 0.001). The patients’ profile regarding age, gender, severity, cholestasis
incidence and mortality were similar during the first and second periods of study (n = 154 and n = 113, respectively).  The
number of patients with hematocrit > 44% was smaller during the second study period (p<0.002). The use of magnetic
resonance cholangiography, videolaparoscopic cholecystectomy, and access to the ICU were found to be more frequent
during the second study period. Regarding the deaths occurring within 14 days of hospitalisation, 73.4% and 81.3% were
observed during the first and second study periods, respectively. Conclusion: Since the improvement in clinical and
technological approach was not enough to modify the mortality profile of ABP, further studies on the treatment of
inflammatory responses should be carried out.
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RESUMO
Objetivo:Avaliou-se a influência do acesso aos recursos assistenciais e tecnológicos sobre a mortalidade na pancreatite
aguda biliar (PAB). Métodos: Os casos de PAB tratados num hospital universitário foram estudados em dois períodos:
1995 a 1999 e 2000 a 2004,  antes e depois da implantação da Regulação Médica. Resultados: Do total de 727 casos com
pancreatite aguda atendidos,  267 apresentavam PAB e tiveram a  gravidade  avaliada  pelo escore de APACHE II. Houve
redução dos encaminhamentos de casos entre os períodos, de 441 para 286 (p < 0,001). O perfil dos pacientes com PAB no
primeiro período (n = 154) e no segundo (n =113) foi semelhante quanto à idade, sexo, gravidade, incidência de colestase
e mortalidade. A incidência de pacientes com hematócrito > 44 foi menor no segundo período (p < 0,002). O emprego de
colangiografia por ressonância magnética, da colecistectomia por videolaparoscopia e do acesso à terapia intensiva foi
significantemente maior no segundo período. A maioria dos óbitos ocorreu até os 14 dias de admissão, 73,4% no primeiro
período e 81,3% no segundo. Conclusão:A melhora do suporte tecnológico e clínico não foi suficiente para modificar o
perfil de mortalidade na PAB, o que indica a necessidade de avaliar terapêuticas   para a sua resposta inflamatória.
Descritores: Pancreatite Biliar. APACHE II. Regulação Médica. Colestase. Mortalidade. Emergência.
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Introduction
In the great majority of cases, severe acute
pancreatitis occurs in two phases. During the first couple
of weeks, a systemic inflammatory reaction occurs due to
the release of various pro-inflammatory cytokines, such as
tumour necrosis factor (TNF), interleukins (IL-1, IL-2, IL-6),
nitric oxide, oxygen-reactive radicals, and arachidonic acid
metabolites.1 Two weeks later, pancreatic necrosis and
peripancreatic infection with multiple organ failure may
occur.2.
The overall mortality of acute pancreatitis is 5%
(ranging from 2 to 9%), including all other aetiologies.3 The
mortality occurring during the early phase (two first weeks)
ranges from 0 to 82.3%.4,5 However, the efforts in identifying
mortality determinants in order to develop new therapeutic
approaches have not yielded promising results.5-7
In the literature there is no study on the mortality
profile of acute biliary pancreatitis (ABP) regarding early
and late phases, which justifies an evaluation of the
possible determinants involved.
In 2000, in an attempt to improve the diagnostic
and treatment conditions of acute severe cases seen in the
emergency settings, a medical regulation was applied to
the ambulance service emergency care (SAMU) which
covers the greater Ribeirão Preto.8
Medical regulation has the objective of co-
ordinating the available resources according to the health
problem involved, so that the best diagnostic and
therapeutic alternatives can be provided. Since the
implementation of the medical regulation, the Emergency
Unit of the Ribeirão Preto University Hospital has been
considered a reference point in terms of high complexity
cases. As a result, the facilities were architecturally and
technologically improved to provide clinical stabilisation
and intensive care.8,9
Concomitantly, this process of organising the
health care system and establishing inpatient references
may benefit patients with biliary lithiasis because of the
extensive access to videolaparoscopic cholecystectomy.
Outpatient care and long-range care have contributed to
reducing the waiting list for cholecystectomy among these
low-risk surgical patients.10 In addition, magnetic resonance
cholangiography was gradually implemented as part of
examination procedures for biliary duct investigation in the
cases of extra-hepatic cholestasis, thus reducing the need
for more invasive procedures.11,12
Within this context, it is expected that not only the
complications resulting from biliary lithiasis will be reduced,
particularly acute pancreatitis, but also that the access to
emergency units will become more rapid.
The objective of the present study was to evaluate
the influence of medical regulation, hospital organisation,
and resources for cholelithiasis treatment on the mortality
profile of ABP during early and later phases.
Methods
The medical records of patients over 12 years old
who were admitted to the Ribeirão Preto University Hospital
or Emergency Unit between January 1st, 1995 and  December
31st, 2004 for ABP treatment were retrospectively reviewed.
Information was collected according to the International
Disease Code (ICD 9 – 577.0 and ICD 10 – K 85.0).
The study was divided into two periods of time:
1995 to 1999 and 2000 to 2005. This temporal division was
based on the date of implementation of SAMU and medical
regulation in the greater Ribeirão Preto area, that is, the
periods before and after the year 1999.
The individual data were gathered according to
the medical record review protocol. Epidemiological and
clinical information, image and pathological exams, and
diagnostic and therapeutic procedures were tabulated on
electronic spreadsheets (Microsoft Excel, Seattle, USA).
ABP diagnosis was based on the presence of at
least two or three criteria:  1) upper abdominal pain, 2) serum
levels of amylase and/or lipase > 3 times their normal values;
3) computed tomography (CT) or magnetic resonance (MR)
findings commonly observed in acute pancreatitis.3 The
presence of biliary lithiasis was diagnosed using abdominal
CT, MR or ultrasonography. ABP severity was evaluated
according to both APACHE II score13 and Atlanta
classification.14 Data for the first 24 hours of hospitalisation
were collected for evaluation using APACHE II score. If
this information was not available, a corresponding normal
value was used instead.
Mortality was considered precocious if death
occurred within 14 days following admission. The APACHE
II score was calculated using an electronic plan available at
www.sfar.org/scores2.
The differences between the mean APACHE II values
and the percent death risk were determined by the Student
“t” test, the frequencies were evaluated by the Fisher exact
test and the Pearson Chi-square test, and the medians were
evaluated by the Mann-Whitney test.
The values obtained were expressed as mean and
standard deviation, with the level of significance set at α =
0.05 (P < 0.05). The frequencies were expressed as percent
values. Bonferroni correction was applied to multiple intra-
period comparisons. A receiver operating characteristic
(ROC) curve was constructed to validate the APACHE I
score.
Results
A total of 727 cases of acute pancreatitis were
diagnosed over the 10-year evaluation period, 441 (60.7%)
being treated between 1995-1999 and 286 (39.3%) between
2000-2004. A significant decrease (p < 0.001) in the
emergency referrals was found, mainly regarding cases of
alcohol-related acute pancreatitis (Figure 1).
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Of all cases evaluated, 267 had biliary involvement
(36.7%), 154 being treated during the first study period
(34.9%) and 113  during the second (39.5%).
No significant differences were found between
groups regarding gender (p = 0.887), age (p = 0.959),
severity (p =0.873), APACHE II score (p = 0.224), cholestasis
incidence (p = 0.504), length of hospitalisation (p = 0.630),
and progress to death or survival (p= 0.268). Nevertheless,
the prevalence of patients with hematocrit > 44% was found
to be significantly lower during the second study period (p
< 0.002).
With respect to the image exams used to diagnose
biliary involvement in the cases of acute pancreatitis, a
significant increase was observed in magnetic resonance
cholangiography. Among the therapeutic procedures,
videolaparoscopic cholecystectomy was increasingly used
while both open cholecystectomy and endoscopic
retrograde cholangiopancreatography were decreasingly
used following a 72-hour period (Table 1).
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Cholestasis was observed in almost 60% of the
patients during both study periods. Investigation by means
of MRC was significantly more frequent during the second
study period, whereas a non-significant decrease in the
use of ERCP and intra-operative cholangiography was
observed.  The incidence of choledocholithiasis was low
during both study periods, with no significant difference
between them (Table 2).
The use of intensive care for patients with severe
ABP increased significantly during the second study period,
although only 40% of the cases had been successful. Despite
being statistically equivalent, the estimated 3-day period
on a waiting list was found to be long, even during the
second study period (Table 3).
The overall mortality rate for ABP cases was 11.6%.
Mild ABP (APACHE II < 8) accounted for 68.2% (mortality
rate of 3.8%) and 67.3% (mortality rate of 3.9%) of all cases,
respectively, during the first and second study periods. In
contrast, severe ABP represented 31.8% (mortality rate of
22.4%) and 32.7% (mortality rate of 35.1%) of all cases,
respectively, during the first and second study periods. No
significant difference was found between study periods
(Figure 2).
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Approximately 70% of the deaths occurred within
two weeks after the onset of the disease. During this first
phase, 69.5% of the deaths were related to the systemic
inflammatory response syndrome (SIRS), whereas
sepsis was predominant (87.5%) during the second
phase (Table 4).
A ROC curve was drawn for the APACHE II score.
The sensitivity (74.2%) and specificity (81.2%) for the
prediction of death were based on the APACHE II score (>
8.5) (Figure 3).
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Discussion
The evaluation of the influence of organization of
the health system, of hospital service and of its
technological incorporation into the profile of severity and
the mortality rate in ABP is a novelty. When the present
study was formulated the expectation was that the incidence
of ABP cases would be reduced among patients of good
anaesthetic and surgical risk as a function of the expanded
access to the treatment of colelithiasis by videolaparoscopy
on an ambulatory basis and eventually due to the increased
frequency of more serious cases at the reference hospital
because of the application of medical regulation8,9,10.
The objective of this two-phased study was to
determine the impact of a more extensive access to the
treatment of symptomatic cholelithiasis on the mortality
profile and rates of ABP. This includes videolaparoscopic
cholecystectomy and non-invasive evaluation of the biliary
ducts by means of MRC. By comparing the two study
periods, it can be seen that the number of cholecystectomies
was increased in the Ribeirão Preto region. Based on the
information obtained from the Data Processing Centre of
the Department of Social Medicine, School of Medicine of
Ribeirão Preto, University of São Paulo, cholecystectomy
was performed 12,936 times between 1995 and 1999 and
15,327 times between 2000 and 2004, an increase of 18.5%.
The access to videolaparoscopic cholecystectomy
increased from 29% to 64% at the Ribeirão Preto University
Hospital.
The access to health care services by means of
medical regulation has significantly improved the working
conditions as well as the emergency care unit. Between the
years of 1999 and 2000, a significant reduction in the number
of consultations was observed, from 114,311 to 56,752. Also,
the number of inpatient beds decreased from 113.3 to 97.1%.
Concomitantly, the hospital wards were redefined and the
number of beds for critical patients was increased from 16
(7.1%) to 43 (21%) units compared to the total inpatient
beds.8,9
Within this changing scenario, an overall reduction
of 35.1% was observed in all cases of acute pancreatitis
referred to the emergency care unit after implementation of
both medical regulation and SAMU, despite the fact that
the general population increased by 11.5% during the study
period. In addition, alcohol-related acute pancreatitis and
biliary pancreatitis respectively decreased by 55.3% and
26.6%. However, ABP was found to be slightly increased
(4.6%) during the 2000-2004 study period.
Because of the decreased number of patients, the
more severe cases of ABP were expected to be referred to
the emergency care unit. However, this fact was not
observed. Not only the proportion of cases of mild ABP
seen during both the first and second periods of study, but
also the disease profile regarding age, gender, cholestasis
incidence, severity, APACHE II score, and mortality were
the same.  However, a lower number of patients with
haemoconcentration (P < 0.002) was seen in the second
study period, thus indicating improvement in the clinical
care services.
Even though clinical care was improved and access
to MRC, VLC, and intensive care was significantly extended,
the mortality profile of ABP was not sufficiently modified in
the second-period cases despite the resources available.
During both study periods, the overall mortality
rate for ABP was 11.6%, which is slightly higher than the
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maximum value  reported in the literature on acute
pancreatitis (ranging from 2% to 9%).3
No difference in the mortality rate of patients with
mild ABP was found between the two study periods, a
finding also observed in severe ABP. The overall mortality
rate for patients with mild ABP was 3.8%, similar to that
reported elsewhere (3.0%, ranging from 1% to 7%).3 In the
present study, the overall mortality rate for severe ABP was
27.9%, which corresponds to the limits found in the literature
(17%, ranging from 8% to 39%).3 However, significant
differences in age and APACHE II score were found
between patients who survived and those who died, a
finding already observed in other study on pancreatitis of
various aetiologies.2
The determinants of high mortality during the early
phase of ABP are not known. Clinical stabilisation can be
an important factor to avoid multiple organ failure (MOF),
thus reducing the mortality rate.5 Another factor playing a
relevant role in ABP evolution is the time elapsed between
onset of the symptoms and hospitalisation, including the
intensive care.2 Although the access to intensive care was
found to be extensive during the second study period, the
time elapsed between admission to the hospital and referral
to intensive care did not change, with the first 72 hours
remaining uncovered and corresponding to the period
during which 33.3% and 50.0% of the deaths were
concentrated in the first and second phase of the study,
respectively. Of the patients who died, 70% were males over
70 years old (mean age:  74 + 10.4 years).
There is a great discrepancy between the mortality
and morbidity profiles of acute severe pancreatitis. Mortality
in the early phase ranged from 0 to more than 80.0%.2,4,5 It
seems that precocious organ failure is determined by the
extent to which necrosis affects the pancreatic parenchyma.
In addition, organ failure diagnosed at admission increases
the risk of MOF since 80% of the patients with acute severe
pancreatitis characterised within 72 hours end up
developing MOF despite the intensive care they receive. It
should be noted that the progression of organ failure
resulting from the disease itself during the first week of
hospitalisation is associated with an increased mortality
rate.7
In the present study, most deaths occurred during
the first two weeks, the main cause being the systemic
inflammatory response syndrome (69.5%).  After this 14-
day period, the main cause of death was sepsis (87.5%).
The main therapeutic problem regarding severe acute
pancreatitis is the clinical intensive care for organ failure
recovery.4 Despite the statement that deaths occurring in
the early phase of ABP have been a rare event since the
improvements in the intensive care unit, several studies
have shown that many patients die during the first couple
of weeks following hospitalisation.6 Patients with acute
pancreatitis and MOF complication represent a clinical
challenge in view of the lack of a specific therapy. It was
shown that surgical intervention earlier than 2 weeks after
the onset of symptoms is associated with a prohibitive
mortality rate. Late interventions should be limited to those
patients with necrosis infection, although the mortality rate
remains elevated in the MOF cases regardless of the kind
of surgical intervention.6 On the other hand, recent efforts
have been made to improve the results using minimally
invasive procedures or percutaneous drainage and
antibiotics.14
The APACHE II score has been used during
hospitalisation in order to predict the possibility of death
based on the ROC curve. A sensitivity of 74.2% and
specificity of 81.4% for APACHE score > 8.5 were obtained
in the present study, which were higher than those found
elsewhere, i.e., sensitivity ranging from 68% to 71% and
specificity ranging from 48% to 67% for APACHE II score >
8 during hospitalisation.15
Therefore, in spite of the fact that both medical
regulation and SAMU have reduced the number of patients
being admitted to emergency care units, and despite the
technological and therapeutic resources, the mortality and
severity rates for ABP cases have not been sufficiently
reduced. Early identification of severe cases and immediate
referral to an intensive care unit can open a new perspective
in the evaluation of other therapeutic modalities for treating
the acute inflammatory reaction, which probably will
improve the prognosis for patients with ABP.
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